Developer docs
API playgroundTry for free, no card

Search company profiles

Food Allergy Institute

Full company profile

uuid000a2re

Namestring
Food Allergy Institute
Legal namestring
Food Allergy Institute™
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Food Allergy Institute (FAI), founded in 2015 as a clinical division of the nonprofit TPIRC, operates a vertically integrated food-allergy treatment platform built around the Tolerance Induction Program (TIP). TIP is a 2.5–4 year, AI-driven immunotherapy that uses biosimilar proteins to safely prime the immune system before introducing real-food allergen doses, achieving a 99% success rate with under 1% adverse-event rate versus 20%+ for traditional exposure therapies. The personalization is powered by a proprietary machine-learning model — pioneered by founding engineer Herman Sandhu — that analyzes 300+ biomarkers per patient drawn from Aperture Immunodiagnostics, FAI's in-house CLIA and COLA Certified high-complexity laboratory, and outputs individualized dosing plans using 143 pharmaceutical-grade gummy products manufactured by FAI's in-house Food Laboratory.

FAI sells TIP primarily direct-to-consumer to families of children with severe food allergies, with adult segments (ages 26–50) and complex multi-allergen / comorbid cases (asthma, eczema, EoE, IBS, celiac) as secondary targets. Revenue is split between an all-inclusive cash-pay subscription ($979/month for ages 18 months–25; $1,079/month for adults) and an insurance-based membership ($440/month plus PPO billing through Aetna, Anthem Blue Cross, Cigna, Blue Shield, United Healthcare and others); year-one cash-pay costs are approximately $11,748 with onboarding, launch and food-challenge fees on top. More than 51% of patients travel from outside California, drawn by patient-referral incentives, provider outreach, earned media, and an active community mentorship program.

The organization is scaling physically from two Southern California clinics (Long Beach Willow Clinic and Vista) into new geographies, with an East Bay (Fremont) clinic opening in July 2025 and a Tri-State Area clinic planned for Fall 2026. Operational leadership — drawn from Amgen, Bank of America, Advantage Solutions, Chipotle, and Medtronic — is being layered onto founder Dr. Inderpal Randhawa's clinical and protocol creation role as the institute executes a multi-state build-out funded by patient-subscription revenue rather than external capital.

Short descriptiontext

Food Allergy Institute (FAI) is a nonprofit clinical and research center that treats children and adults with severe food allergies using its AI-powered Tolerance Induction Program (TIP), a 2.5–4 year personalized immunotherapy achieving 99% remission success across 13,000+ patients since 2015.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLong Beach, United States
HQ citystring
Long Beach
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
food allergy treatment, immunotherapy services, allergy diagnostics, personalized medicine, clinical immunology
Industry2 codes
1Food Allergy Evaluation & Management
CodeHLAKAAADPrimaryYes
2Allergen Presence & Cross-Contact Verification (ELISA/PCR; allergen cleaning validation)
CodeAFALAHABPrimaryNo
NAICS code1 code
  • Dairy Product Manufacturing3115
SIC code1 code
  • Food And Kindred Products2000
Product category
Food Allergy Treatment Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1TIP Subscription Plan (Cash Pay)
TypeSubscription Recurring
Description

All-inclusive monthly subscription covering tolerance induction program fee, annual diagnostic testing, and clinical office visits. Primary revenue stream for self-pay and international patients. HSA/FSA eligible.

foodallergyinstitute.com
2TIP Membership with Insurance
TypeSubscription Recurring
Description

Monthly membership fee ($440/month) plus insurance billing for clinical services. In-network with most major PPOs. Clinical visits, food challenges, and lab work billed to insurance. TIP Fee remains out-of-pocket.

foodallergyinstitute.com
3Clinical Services Fees
TypeTransaction Fee
Description

Per-visit fees for food challenges ($435/visit), onboarding visits ($3,900), launch visits ($1,460), and annual remission visits. Billed separately from subscription or included in cash bundle.

foodallergyinstitute.com
4SLIT (Sublingual Immunotherapy)
TypeSubscription Recurring
Description

Environmental allergy treatment for patients requiring it. Billed quarterly ($300-$350/quarter). Not covered by insurance.

foodallergyinstitute.com
Marketing channels13 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details8 tiers
1TIP Subscription Plan for ages 18 months - 25 years
ModelSubscriptionBilling cadenceMonthly
Notes

$979/month all-inclusive covering TIP Fee, annual diagnostic testing, and clinical office visits. HSA/FSA eligible.

foodallergyinstitute.com
2TIP Subscription Plan for ages 26-50 years
ModelSubscriptionBilling cadenceMonthly
Notes

$1,079/month all-inclusive for adult patients.

foodallergyinstitute.com
3TIP Membership with Insurance
ModelSubscriptionBilling cadenceMonthly
Notes

$440/month membership fee plus insurance billing for clinical services. TIP Fee portion ($5,280/year) is not billable to insurance.

foodallergyinstitute.com
4Year 1 Onboarding Visit (Zone 1)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Office Visit (New)/Virtual Onboarding 99205: $450; Skin Prick Test 95018: $950; Blood Draw: $2,500. Total: $3,900.

foodallergyinstitute.com
5Launch Visit (Zone 1)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Office Visit 99215: $240; Skin Patch Test: $625; PFT: $120; ENO Test: $40; Challenge Visit: $435. Total: $1,460.

foodallergyinstitute.com
6Food Challenge Visits (Zone 1)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Approximately 11 visits/year at $435/visit = $4,785/year. In clinic every 6-8 weeks.

foodallergyinstitute.com
7SLIT (Sublingual Immunotherapy)
ModelSubscriptionBilling cadenceMonthly
Notes

$300-$350/quarter depending on zone. Not billable to insurance.

foodallergyinstitute.com
8Insurance-covered PPO Plans
ModelHybridBilling cadenceMonthly
Notes

In-network with Aetna, Anthem Blue Cross, Cigna, Blue Shield of California, Health Net, United Healthcare, Oxford Health, UMR, Multiplan, First Health, Blue Cross Blue Shield (outside CA), Tricare. PPO may cover up to 50% of costs.

foodallergyinstitute.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1TIP (Tolerance Induction Program)
Description

The core treatment program - a personalized, data-driven food allergy treatment using real foods to build tolerance through AI-powered protocols

foodallergyinstitute.com
+2 more records
Core offering1 text field

Food Allergy Institute provides AI-powered, personalized food allergy treatment through its Tolerance Induction Program (TIP), which uses machine learning analysis of patient biomarkers and biosimilar proteins to safely build tolerance to food allergens over a 2.5-4 year course, achieving remission rather than mere desensitization. Treatment is delivered through Southern California clinics, supplemented by pharmaceutical-grade gummy dosing products manufactured in-house and a CLIA-certified diagnostic laboratory for component-resolved testing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 99% success rate for patients completing TIP program
+5 more records
Product overview1 text field

Food Allergy Institute operates as a unified food allergy treatment platform centered on the Tolerance Induction Program (TIP), an AI-powered personalized immunotherapy that analyzes 300+ biomarkers to create individualized treatment plans. The core offering combines the TIP program with proprietary pharmaceutical-grade gummy dosing products manufactured in-house, supported by the Aperture Immunodiagnostics CLIA-certified laboratory. Patients can access treatment through either the all-inclusive TIP Subscription Plan ($979-$1,079/month) or the TIP Membership with Insurance plan, with optional Sublingual Immunotherapy (SLIT) add-on for environmental allergies. The TIP Connect patient portal enables enrollment and ongoing program management.

Product and service7 records
1Tolerance Induction Program (TIP)
CategoryClinical Treatment Program
Description

Personalized AI-driven food allergy treatment program for patients aged 18 months to 50 years that uses real natural foods and biosimilar proteins to build tolerance and achieve lasting food freedom.

2TIP Subscription Plan
CategorySubscription Payment Plan
Description

All-inclusive cash-pay monthly subscription covering TIP program fee, annual diagnostic testing, and clinical office visits at $979/month for ages 18 months-25 years and $1,079/month for ages 26-50 years. HSA/FSA eligible.

3TIP Membership with Insurance
CategoryInsurance Payment Plan
Description

Insurance-based membership plan at $440/month with insurance billed for clinical services and diagnostic tests; available with major PPO carriers including Aetna, Cigna, Blue Shield, Anthem, United Healthcare, and others.

4TIP Gummy Doses
CategoryProprietary Dosing Products
Description

Pharmaceutical-grade gummy doses containing precise milligram amounts of nuts, grains, seeds, or legumes for at-home dosing during TIP treatment; 143 unique formulations manufactured in-house by Food Laboratory Scientists.

5Aperture Immunodiagnostics
CategoryDiagnostic Laboratory Services
Description

CLIA and COLA certified high-complexity diagnostic laboratory performing component-resolved blood testing for 130+ allergens and hundreds of biomarkers, supporting TIP treatment planning and therapeutic monitoring.

6Sublingual Immunotherapy (SLIT)
CategoryAdjunct Therapy Service
Description

Environmental allergy treatment administered under the tongue for patients requiring management of cross-reacting environmental allergies during TIP, billed quarterly at $300-$350.

7TIP Connect
CategoryPatient Portal Platform
Description

Patient portal for TIP families to access enrollment forms, grant requests, FSA/HSA documentation, provider communications, and program management tools.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership providing rental car discounts for traveling TIP families. Account #: XZ32748. Located at airports and local neighborhoods. Discounts vary based on booking time and availability.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Rental car partnership providing discounts for TIP families traveling to clinics. Discounts vary based on booking time and availability.

3Aperture Immunodiagnostics
Strategic tierCoreTypeTechnology or Integration
Description

CLIA and COLA Certified high-complexness laboratory that is part of TPIRC ecosystem. Performs component-resolved diagnostic testing for 130+ allergen components essential for TIP treatment planning. Only diagnostic facility with complete test set for TIP protocols.

foodallergyinstitute.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Non-profit parent organization of Food Allergy Institute. Focuses on development of cutting-edge treatment protocols for rare and orphan diseases using comprehensive diagnostic tools and patient-driven research. Houses TPIRC Biobank for biological samples and patient data supporting food anaphylaxis research.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partner hotel in Long Beach offering corporate rates for TIP families. Address: 700 Queensway Dr., Long Beach, CA 90802. Corporate Code: P75.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partner hotel in Long Beach with negotiated rates for TIP families traveling to clinics. Address: 200 South Pine Avenue, Long Beach CA 90802.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partner hotel with kitchen suites ideal for TIP families on extended treatment visits. Corporate Code: 3249070.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partner hotel near Vista clinic with negotiated rates. Address: 2645 South Melrose Dr., Vista CA 92081.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partner hotel near Orange County clinic with shuttle transportation to clinic, complimentary parking, and World of Hyatt points. Address: 5905 Corporate Ave, Cypress, CA 90630.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Southwest Companion Pass benefit referenced for TIP families - allows qualifying members to bring a companion fly free (excluding taxes and fees).

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partner hotel near Fremont (East Bay) clinic location. Address: 3101 W Warren Ave, Fremont, CA 94538.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Clinical-stage company developing a novel oral mucosal immunotherapy (OMIT) platform for food and environmental allergies. Comparable to FAI as an alternative food allergy immunotherapy developer, though pursuing a more conventional pharma approval pathway.

TypeEmerging player
Description

Developer of the Viaskin epicutaneous immunotherapy patch for peanut and other food allergies. Comparable as a food allergy immunotherapy modality competitor with a differentiated delivery mechanism (skin patch), though it has yet to achieve broad commercial scale.

TypeDirect peer
Description

A major academic food allergy treatment and research center at the Icahn School of Medicine. Directly comparable to FAI as a specialty food allergy clinical program, though predominantly operating in an academic/research setting rather than a subscription-based clinical model.

TypeDirect peer
Description

Leading pediatric food allergy clinical and research program at a top academic medical center. Competes for the same severe pediatric food allergy patient population and conducts OIT and related immunotherapies within an academic framework.

TypeBroad incumbent
Description

Maker of Xolair (omalizumab), which received FDA approval in 2024 to reduce allergic reactions to multiple foods. A broad pharmaceutical incumbent offering a biologic option for food allergy risk reduction that competes for the same patient pool as FAI's TIP.

TypeOthers
Description

Consumer health company focused on early allergen introduction products for infants to prevent food allergies. Adjacent to FAI's mission (reducing food allergy burden) but operates in prevention rather than treatment, with a direct-to-consumer product model rather than clinical care.

TypeRegional player
Description

Academic research consortium at Stanford focused on food allergy pathogenesis, treatment, and prevention. Operates as a research-driven food allergy program in Northern California—adjacent to FAI's footprint—and overlaps in patient demographic and investigator focus.

TypeDirect peer
Description

One of the highest-volume pediatric food allergy treatment centers in the US, with active OIT and multi-food allergen programs. Directly comparable to FAI in clinical scope, with a similar emphasis on treating complex multi-allergen pediatric cases.

TypeBroad incumbent
Description

Developer of Palforzia, the first FDA-approved oral immunotherapy for peanut allergy (now part of Nestlé Health Science). Overlaps with FAI on food allergy OIT but focuses on a single FDA-approved biologic rather than FAI's broader, multi-allergen personalized protocol.

TypeEmerging player
Description

Clinical-stage biopharmaceutical company developing ADP101, a single multi-food oral immunotherapy candidate designed to address multiple food allergies simultaneously. Directly comparable to FAI's multi-allergen treatment philosophy but pursuing an FDA-regulated pharmaceutical pathway.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Food Allergy Institute

Food Allergy Treatment Servicesfoodallergyinstitute.com

Food Allergy Institute (FAI) is a nonprofit clinical and research center that treats children and adults with severe food allergies using its AI-powered Tolerance Induction Program (TIP), a 2.5–4 year personalized immunotherapy achieving 99% remission success across 13,000+ patients since 2015.

What Food Allergy Institute does

Food Allergy Institute (FAI), founded in 2015 as a clinical division of the nonprofit TPIRC, operates a vertically integrated food-allergy treatment platform built around the Tolerance Induction Program (TIP). TIP is a 2.5–4 year, AI-driven immunotherapy that uses biosimilar proteins to safely prime the immune system before introducing real-food allergen doses, achieving a 99% success rate with under 1% adverse-event rate versus 20%+ for traditional exposure therapies. The personalization is powered by a proprietary machine-learning model — pioneered by founding engineer Herman Sandhu — that analyzes 300+ biomarkers per patient drawn from Aperture Immunodiagnostics, FAI's in-house CLIA and COLA Certified high-complexity laboratory, and outputs individualized dosing plans using 143 pharmaceutical-grade gummy products manufactured by FAI's in-house Food Laboratory.

FAI sells TIP primarily direct-to-consumer to families of children with severe food allergies, with adult segments (ages 26–50) and complex multi-allergen / comorbid cases (asthma, eczema, EoE, IBS, celiac) as secondary targets. Revenue is split between an all-inclusive cash-pay subscription ($979/month for ages 18 months–25; $1,079/month for adults) and an insurance-based membership ($440/month plus PPO billing through Aetna, Anthem Blue Cross, Cigna, Blue Shield, United Healthcare and others); year-one cash-pay costs are approximately $11,748 with onboarding, launch and food-challenge fees on top. More than 51% of patients travel from outside California, drawn by patient-referral incentives, provider outreach, earned media, and an active community mentorship program.

The organization is scaling physically from two Southern California clinics (Long Beach Willow Clinic and Vista) into new geographies, with an East Bay (Fremont) clinic opening in July 2025 and a Tri-State Area clinic planned for Fall 2026. Operational leadership — drawn from Amgen, Bank of America, Advantage Solutions, Chipotle, and Medtronic — is being layered onto founder Dr. Inderpal Randhawa's clinical and protocol creation role as the institute executes a multi-state build-out funded by patient-subscription revenue rather than external capital.

Food Allergy Institute firmographics

Firmographics
Name
Food Allergy Institute
Legal name
Food Allergy Institute™
Website
https://foodallergyinstitute.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
101–250 employees
Short description
Food Allergy Institute (FAI) is a nonprofit clinical and research center that treats children and adults with severe food allergies using its AI-powered Tolerance Induction Program (TIP), a 2.5–4 year personalized immunotherapy achieving 99% remission success across 13,000+ patients since 2015.
Ownership category
akta.pro rank

Food Allergy Institute industry classification

Industry
Product category
Food Allergy Treatment Services
NAICS
Dairy Product Manufacturing (3115)
SIC
Food And Kindred Products (2000)
akta.pro primary industry
Food Allergy Evaluation & Management (HLAKAAAD)
akta.pro secondary industry
Allergen Presence & Cross-Contact Verification (ELISA/PCR; allergen cleaning validation) (AFALAHAB)

Keywords

  • Food allergy treatment
  • Immunotherapy services
  • Allergy diagnostics
  • Personalized medicine
  • Clinical immunology

Where Food Allergy Institute is headquartered

Location

Headquarters

HQ city
Long Beach
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Food Allergy Institute business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. TIP Subscription Plan (Cash Pay): All-inclusive monthly subscription covering tolerance induction program fee, annual diagnostic testing, and clinical office visits. Primary revenue stream for self-pay and international patients. HSA/FSA eligible.
  2. TIP Membership with Insurance: Monthly membership fee ($440/month) plus insurance billing for clinical services. In-network with most major PPOs. Clinical visits, food challenges, and lab work billed to insurance. TIP Fee remains out-of-pocket.
  3. Clinical Services Fees: Per-visit fees for food challenges ($435/visit), onboarding visits ($3,900), launch visits ($1,460), and annual remission visits. Billed separately from subscription or included in cash bundle.
  4. SLIT (Sublingual Immunotherapy): Environmental allergy treatment for patients requiring it. Billed quarterly ($300-$350/quarter). Not covered by insurance.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyTIP Subscription Plan for ages 18 months - 25 years
SubscriptionMonthlyTIP Subscription Plan for ages 26-50 years
SubscriptionMonthlyTIP Membership with Insurance
Unit PricingPay-as-you-goYear 1 Onboarding Visit (Zone 1)
Unit PricingPay-as-you-goLaunch Visit (Zone 1)
Unit PricingPay-as-you-goFood Challenge Visits (Zone 1)
SubscriptionMonthlySLIT (Sublingual Immunotherapy)
HybridMonthlyInsurance-covered PPO Plans

Go-to-market motion3 records

Distribution channels5 records

Marketing channels13 records

Food Allergy Institute product offering

Product offering

Core offering

Food Allergy Institute provides AI-powered, personalized food allergy treatment through its Tolerance Induction Program (TIP), which uses machine learning analysis of patient biomarkers and biosimilar proteins to safely build tolerance to food allergens over a 2.5-4 year course, achieving remission rather than mere desensitization. Treatment is delivered through Southern California clinics, supplemented by pharmaceutical-grade gummy dosing products manufactured in-house and a CLIA-certified diagnostic laboratory for component-resolved testing.

Product overview

Food Allergy Institute operates as a unified food allergy treatment platform centered on the Tolerance Induction Program (TIP), an AI-powered personalized immunotherapy that analyzes 300+ biomarkers to create individualized treatment plans. The core offering combines the TIP program with proprietary pharmaceutical-grade gummy dosing products manufactured in-house, supported by the Aperture Immunodiagnostics CLIA-certified laboratory. Patients can access treatment through either the all-inclusive TIP Subscription Plan ($979-$1,079/month) or the TIP Membership with Insurance plan, with optional Sublingual Immunotherapy (SLIT) add-on for environmental allergies. The TIP Connect patient portal enables enrollment and ongoing program management.

Differentiator

Problem solved

Functional benefit

Brands

  • TIP (Tolerance Induction Program): The core treatment program - a personalized, data-driven food allergy treatment using real foods to build tolerance through AI-powered protocols
  • TIP Connect
  • Food Freedom

Products and services

  • Tolerance Induction Program (TIP) Personalized AI-driven food allergy treatment program for patients aged 18 months to 50 years that uses real natural foods and biosimilar proteins to build tolerance and achieve lasting food freedom.
  • TIP Subscription Plan All-inclusive cash-pay monthly subscription covering TIP program fee, annual diagnostic testing, and clinical office visits at $979/month for ages 18 months-25 years and $1,079/month for ages 26-50 years. HSA/FSA eligible.
  • TIP Membership with Insurance Insurance-based membership plan at $440/month with insurance billed for clinical services and diagnostic tests; available with major PPO carriers including Aetna, Cigna, Blue Shield, Anthem, United Healthcare, and others.
  • TIP Gummy Doses Pharmaceutical-grade gummy doses containing precise milligram amounts of nuts, grains, seeds, or legumes for at-home dosing during TIP treatment; 143 unique formulations manufactured in-house by Food Laboratory Scientists.
  • Aperture Immunodiagnostics CLIA and COLA certified high-complexity diagnostic laboratory performing component-resolved blood testing for 130+ allergens and hundreds of biomarkers, supporting TIP treatment planning and therapeutic monitoring.
  • Sublingual Immunotherapy (SLIT) Environmental allergy treatment administered under the tongue for patients requiring management of cross-reacting environmental allergies during TIP, billed quarterly at $300-$350.
  • TIP Connect Patient portal for TIP families to access enrollment forms, grant requests, FSA/HSA documentation, provider communications, and program management tools.

Quantifiable outcome

  • 99% success rate for patients completing TIP program
  • +5 more outcomes

Companies that use Food Allergy Institute

Customer profile

Segments4 records

Ideal customer profiles3 records

Food Allergy Institute technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Food Allergy Institute partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered minor and core.

  • Enterprise Rent-A-CarminorGTM or Marketing PartnerPartnership providing rental car discounts for traveling TIP families. Account #: XZ32748. Located at airports and local neighborhoods. Discounts vary based on booking time and availability.
  • National Car RentalminorGTM or Marketing PartnerRental car partnership providing discounts for TIP families traveling to clinics. Discounts vary based on booking time and availability.
  • Aperture ImmunodiagnosticscoreTechnology or IntegrationCLIA and COLA Certified high-complexness laboratory that is part of TPIRC ecosystem. Performs component-resolved diagnostic testing for 130+ allergen components essential for TIP treatment planning. Only diagnostic facility with complete test set for TIP protocols.
  • TPIRC (Translational Pulmonary and Immunology Research Center)coreStrategic or Co-development PartnerNon-profit parent organization of Food Allergy Institute. Focuses on development of cutting-edge treatment protocols for rare and orphan diseases using comprehensive diagnostic tools and patient-driven research. Houses TPIRC Biobank for biological samples and patient data supporting food anaphylaxis research.
  • Hotel MayaminorGTM or Marketing PartnerPartner hotel in Long Beach offering corporate rates for TIP families. Address: 700 Queensway Dr., Long Beach, CA 90802. Corporate Code: P75.
  • Hyatt Regency Long BeachminorGTM or Marketing PartnerPartner hotel in Long Beach with negotiated rates for TIP families traveling to clinics. Address: 200 South Pine Avenue, Long Beach CA 90802.
  • Homewood Suites by Hilton Long Beach AirportminorGTM or Marketing PartnerPartner hotel with kitchen suites ideal for TIP families on extended treatment visits. Corporate Code: 3249070.
  • Hyatt Place San Diego/Vista-CarlsbadminorGTM or Marketing PartnerPartner hotel near Vista clinic with negotiated rates. Address: 2645 South Melrose Dr., Vista CA 92081.
  • Hyatt House CypressminorGTM or Marketing PartnerPartner hotel near Orange County clinic with shuttle transportation to clinic, complimentary parking, and World of Hyatt points. Address: 5905 Corporate Ave, Cypress, CA 90630.
  • Southwest AirlinesminorGTM or Marketing PartnerSouthwest Companion Pass benefit referenced for TIP families - allows qualifying members to bring a companion fly free (excluding taxes and fees).
  • Hyatt Place FremontminorGTM or Marketing PartnerPartner hotel near Fremont (East Bay) clinic location. Address: 3101 W Warren Ave, Fremont, CA 94538.

Scale indicators10 records

Recent moves8 records

Expansion highlights5 records

Food Allergy Institute competitors and assessment

Company assessment

Emerging players

  • Intrommune Therapeutics: Clinical-stage company developing a novel oral mucosal immunotherapy (OMIT) platform for food and environmental allergies. Comparable to FAI as an alternative food allergy immunotherapy developer, though pursuing a more conventional pharma approval pathway.
  • DBV Technologies: Developer of the Viaskin epicutaneous immunotherapy patch for peanut and other food allergies. Comparable as a food allergy immunotherapy modality competitor with a differentiated delivery mechanism (skin patch), though it has yet to achieve broad commercial scale.
  • Alladapt Immunotherapeutics: Clinical-stage biopharmaceutical company developing ADP101, a single multi-food oral immunotherapy candidate designed to address multiple food allergies simultaneously. Directly comparable to FAI's multi-allergen treatment philosophy but pursuing an FDA-regulated pharmaceutical pathway.

Direct peers

  • Mount Sinai Jaffe Food Allergy Institute: A major academic food allergy treatment and research center at the Icahn School of Medicine. Directly comparable to FAI as a specialty food allergy clinical program, though predominantly operating in an academic/research setting rather than a subscription-based clinical model.
  • Boston Children's Hospital Food Allergy Program: Leading pediatric food allergy clinical and research program at a top academic medical center. Competes for the same severe pediatric food allergy patient population and conducts OIT and related immunotherapies within an academic framework.
  • Cincinnati Children's Hospital - Food Allergy Center: One of the highest-volume pediatric food allergy treatment centers in the US, with active OIT and multi-food allergen programs. Directly comparable to FAI in clinical scope, with a similar emphasis on treating complex multi-allergen pediatric cases.

Broad incumbents

  • Genentech (Roche) - Xolair: Maker of Xolair (omalizumab), which received FDA approval in 2024 to reduce allergic reactions to multiple foods. A broad pharmaceutical incumbent offering a biologic option for food allergy risk reduction that competes for the same patient pool as FAI's TIP.
  • Aimmune Therapeutics (Nestlé Health Science): Developer of Palforzia, the first FDA-approved oral immunotherapy for peanut allergy (now part of Nestlé Health Science). Overlaps with FAI on food allergy OIT but focuses on a single FDA-approved biologic rather than FAI's broader, multi-allergen personalized protocol.

Others

  • Ready, Set, Food!: Consumer health company focused on early allergen introduction products for infants to prevent food allergies. Adjacent to FAI's mission (reducing food allergy burden) but operates in prevention rather than treatment, with a direct-to-consumer product model rather than clinical care.

Regional players

  • Stanford Alliance for Food Allergy Research (SAFAR): Academic research consortium at Stanford focused on food allergy pathogenesis, treatment, and prevention. Operates as a research-driven food allergy program in Northern California—adjacent to FAI's footprint—and overlaps in patient demographic and investigator focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Food Allergy Institute social profiles

Digital presence

Food Allergy Institute compliance and trust

Trust signal

Compliance2 records

Food Allergy Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Food Allergy Institute leadership team

Management profile

Number of profiles

Profiles10 records

Food Allergy Institute subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Food Allergy Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Food Allergy Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Food Allergy Institute

What does Food Allergy Institute do?

Food Allergy Institute provides AI-powered, personalized food allergy treatment through its Tolerance Induction Program (TIP), which uses machine learning analysis of patient biomarkers and biosimilar proteins to safely build tolerance to food allergens over a 2.5-4 year course, achieving remission rather than mere desensitization. Treatment is delivered through Southern California clinics, supplemented by pharmaceutical-grade gummy dosing products manufactured in-house and a CLIA-certified diagnostic laboratory for component-resolved testing.

Is Food Allergy Institute a public or private company?

Food Allergy Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Food Allergy Institute founded?

Food Allergy Institute was founded in 2015. It employs 101 to 250 people.

Where is Food Allergy Institute based?

Food Allergy Institute is headquartered in Long Beach, United States, in the North America region.

How does Food Allergy Institute make money?

Four revenue lines are on record. TIP Subscription Plan (Cash Pay) is the primary driver. The others are TIP Membership with Insurance, clinical Services Fees and SLIT (Sublingual Immunotherapy).

Who are Food Allergy Institute's main competitors?

Emerging players on record are Intrommune Therapeutics, DBV Technologies and Alladapt Immunotherapeutics. Direct peers are Mount Sinai Jaffe Food Allergy Institute, Boston Children's Hospital Food Allergy Program and Cincinnati Children's Hospital - Food Allergy Center. Broad incumbents are Genentech (Roche) - Xolair and Aimmune Therapeutics (Nestlé Health Science). Ready, Set, Food! is listed as an others. Stanford Alliance for Food Allergy Research (SAFAR) is listed as a regional player.

Does Food Allergy Institute have an API?

No public API is recorded for Food Allergy Institute.

What industry is Food Allergy Institute in?

Food Allergy Institute's product category is Food Allergy Treatment Services. Its primary akta.pro industry code is HLAKAAAD, Food Allergy Evaluation & Management, with a secondary code of AFALAHAB, Allergen Presence & Cross-Contact Verification (ELISA/PCR; allergen cleaning validation). Its NAICS code is 3115 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals